Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439763 · ClinicalTrials.gov registry record
Assessment of Bullying in Children
A clinical trial of Problematic Behavior in Children, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT01439763: Completed study of Problematic Behavior in Children, sponsored by New York City Health and Hospitals Corporation.
NCT01439763 is a study of Problematic Behavior in Children that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01439763, a study of Problematic Behavior in Children, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aims of this study are: * To determine the prevalence of bullying in children who present to the ED with behavioral symptoms * To assess mental health diagnoses and their relationship to type, severity and frequency of bullying behaviors, as well as demographic and psychosocial correlates (socioeconomic status, stress and support) and their relationship to type, severity and frequency of bullying (bullies versus victims). * To explore the attitudes, values, triggering events and potential solutions using qualitative methods * To gain greater insight into the patient experience and perceptions of the bullying events
Primary Outcome
Bullying incidents
Conditions Studied
Study Locations (1)
New York
- Lincoln Medical & Mental Health Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-09 |
| Est. Completion | 2020-11-15 |
What the finished NCT01439763 record still lists
NCT01439763 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 1 condition, with Problematic Behavior in Children appearing as the primary indexed condition, and to 0 interventions.
NCT01439763 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01439763 about?
NCT01439763 is a clinical study titled "Assessment of Bullying in Children". The specific aims of this study are: * To determine the prevalence of bullying in children who present to the ED with behavioral symptoms * To assess mental health diagnoses and their relationship to type, severity and frequency of bullying behaviors, as well as demographic and psychosocial correla...
What is the current status of trial NCT01439763?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2011-09. Estimated completion is 2020-11-15.
What conditions does trial NCT01439763 study?
This clinical trial studies the following conditions: Problematic Behavior in Children.
Who is sponsoring clinical trial NCT01439763?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01439763 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia